基于公平的优化对COVID-19疫苗分配的回顾性分析
Erin Stafford1, Dobromir Dimitrov1,2, Rachel Ceballos3,4
1Department of Applied Mathematics, University of Washington, Seattle, WA, USA.
PNAS nexus
|September 11, 2023
概括
COVID-19疫苗分配策略揭示了减少疾病负担和尽量减少种族不平等之间的权衡. 增加疫苗供应是优化两者的关键,特别是在边缘化社区.
科学领域:
- 流行病学 流行病学
- 数学建模的数学建模
- 公共卫生政策 公共卫生政策
背景情况:
- 边缘化的种族和民族群体在美国经历了不成比例的COVID-19影响.
- 了解和解决这些健康差异对于有效的公共卫生干预至关重要.
研究的目的:
- 开发和分析针对SARS-CoV-2传播的种族意识的数学模型.
- 评估旨在最大限度地减少疾病负担和种族不平等的反事实性COVID-19疫苗接种策略.
主要方法:
- 构建了SARS-CoV-2传播的年龄和种族分层数学模型.
- 将模型与2020年俄勒冈州数据相匹配,按非西班牙裔白人和BIPOC群体进行分层.
- 分析了2021年初在有限的疫苗供应的情况下假设的疫苗接种策略.
主要成果:
- 在减少总体疾病负担和种族不平等之间存在一种权衡,疫苗覆盖率低 (10%).
- 优先考虑疾病负担有利于老年群体;优先考虑公平有利于年轻的BIPOC群体.
- 增加的疫苗供应 (20-30%的覆盖率) 显著减少了权衡,使得公平性和死亡率的优化成为可能.
结论:
- 数学建模为量化和最小化公共卫生干预中的种族不平等提供了一个框架.
- 疫苗分配战略必须考虑疾病负担和公平性,供应是关键因素.
- 为了解决当前和未来的流行病中健康差异,必须采取种族意识的方法.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
Statistical Methods for Analyzing Epidemiological Data
403
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
403
Analysis of Population Pharmacokinetic Data
291
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
291
Pharmacokinetic Models: Comparison and Selection Criterion
103
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
103
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
174
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
174
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K


